Increased Serum Cu/Zn SOD in Individuals with Clinical Depression Normalizes after Zinc and Anti-oxidant Therapy

Nutrition and Metabolic Insights

Volumn 3, Issue , 2010, Pages

  Russo, A J ^a  

^a Pfeiffer Treatment Center   (United States)

Author keywords

Cu Zn SOD; depression; oxidative stress; super oxide dismutase

Indexed keywords

EID: 85133324858     PISSN: None     EISSN: 11786388     Source Type: Journal    
DOI: 10.4137/NMI.S5044     Document Type: Article

References (43)

1. Cassano P., Fava M. Depression and public health: an overview. J Psychosom Res. 2002; 53: 849–57.
2. Kessler R.C., Berglund P., Demler O. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289: 3095–105.
3. Lett H.S., Blumenthal J.A., Babyak M.A. et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004; 66: 305–15.
4. Rudisch B., Nemeroff C.B. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003; 54: 227–40.
5. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998; 55: 580–92.
6. Musselman D.L., Betan E., Larsen H., Phillips L.S. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003; 54: 317–29.
7. Eaton W.W. Epidemiologic evidence on the comorbidity of depression and diabetes. J Psychosom Res. 2002; 53: 903–6.
8. Eaton W.W., Armenian H., Gallo J., Pratt L., Ford D.E. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996; 19: 1097–102.
9. Penninx B., Guralnik J., Pahor M. et al. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst. 1998; 90: 1888–93.
10. Raison C.L., Miller A.H. Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry. 2003; 54: 283–94.
11. Spiegel D., Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry. 2003; 54: 269–82.
12. Larson S.L., Owens P.L., Ford D., Eaton W. Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke. 2001; 32: 1979–83.
13. Jackson A.L., Loeb L.A. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res. 2001; 477: 7–21.
14. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis. 2000; 21: 361–70.
15. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis. 1990; 11: 1447–50.
16. Andreassi M.G., Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med. 2003; 13: 270–5.
17. Botto N., Masetti S., Petrozzi L. et al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis. 2002; 13: 269–74.
18. Martinet W., Knaapen M.W.M., De Meyer G.R.Y., Herman A.G., Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation. 2002; 106: 927–32.
19. Botto N., Rizza A., Colombo M.G. et al. Evidence for DNA damage in patients with coronary artery disease. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2001; 493: 23–30.
20. Sies H. Oxidative stress: Oxidants and Antioxidants. Academic Press; New York: 1991.
21. Malmstrom B.G. Enzymology of oxygen. Annu Rev Biochem. 1982; 51: 21.
22. Forman H.J., Torres M. Redox signaling in macrophages. Mo Aspects Med. 2001; 22: 189.
23. Fridovich I. The biology of oxygen radicals. Science. 1978; 201: 875.
24. Bonham M., O'Connor J.M., Hannigan B.M., Strain J.J. The immune system as a physiological indicator of marginal copper status? Br J Nutr. 2002; 87(5): 393–403.
25. Ozcelik D. et al. Copper-mediated oxidative stress in rat liver Biological Trace Element Research. 2007; 96: 209–15.
26. Irie M., Asami S., Nagata S., Ikeda M., Miyata M., Kasai H. Psychosocial factors as a potential trigger of oxidative DNA damage in human leukocytes. Jpn J Cancer Res. 2001; 92: 367–76.
27. Irie M., Asami S., Nagata S., Miyata M., Kasai H. Relationships between perceived workload, stress and oxidative DNA damage. Int Arch Occup Environ Health. 2001; 74: 153–7.
28. Irie M., Asami S., Ikeda M., Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun. 2003; 311: 1014–8.
29. Krishnan K.R.R., Delong M., Kraemer H. et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry. 2002; 52: 559–88.
30. Herbert T.B., Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993; 113: 472–86.
31. Miller G.E., Freedland K.E., Carney R.M., Stetler C.A., Banks W.A. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun. 2003; 17: 276–85.
32. Miller G.E., Freedland K.E., Duntley S., Carney R.M. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 2005; 95: 317–21.
33. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002; 90: 1279–83.
34. Babior B.M. Phagocytes and oxidative stress. Am J Med. 2000; 109: 33–44.
35. Simic M.G. DNA markers of oxidative processes in vivo: relevance to carcinogenesis and anticarcinogenesis. Cancer Res. 1994; 54: 1918–23.
36. Jackson J.H., Gajewski E., Schraufstatter I.U. et al. Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest. 1989; 84: 1644–9.
37. Shacter E., Beecham E.J., Covey J.M., Kohn K.W., Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis. 1988; 9: 2297–304.
38. Aust A.E., Eveleigh J.F. Mechanisms of DNA oxidation. Proc Soc Exp Biol Med. 1999; 222: 246–52.
39. Kiecolt-Glaser J.K., Stephens R.E., Lipetz P.D., Speicher C.E., Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med. 1985; 8: 311–20.
40. Forlenza M.J. et al. Increased Serum Levels of 8-Hydroxy-2‘-Deoxyguanosine in Clinical Depression Psychosomatic Medicine. 2006; 68: 1–7.
41. Lucca G. et al. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. Journal of Psychiatric Research. 2009; 43: 864–69.
42. Pawlak K., Pawlak D., Mysliwiec M. Cu/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of oxidative stress in patients with end-stage renal disease. Clin Biochem. 2005 Aug; 38(8): 700–5.
43. Olivares M. et al. Present situation of biomarkers for copper status American Journal of Clinical Nutrition, 2008; 88(3): 859S–62.